Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
AU-rich element-containing messenger RNAs harbor **adenylate-uridylate-rich elements (AREs)** within their 3′ untranslated regions, which confer regulatory properties by promoting rapid turnover or modulating translation of the mRNA[4][1][5][6][7]. These elements recruit RNA-binding proteins—such as AUF1, tristetraprolin (TTP), and Hu antigen R (HuR)—that can either destabilize and degrade the mRNA or stabilize it and enhance its translation[4][3][6][7]. Many genes critical for cell growth, immune responses, inflammation, and stress responses are regulated post-transcriptionally via these AREs[5][6][7]. Misregulation of ARE-containing mRNAs is implicated in diseases such as cancer, chronic inflammation, and cardiovascular and autoimmune conditions[6][4]. While not a direct therapeutic target, the ARE regulatory system is an important focus for drug development that aims to modulate the stability of disease-related transcripts by targeting their binding proteins. "AU-rich element-containing mRNA" is a descriptive class of mRNAs regulated via short AU-rich sequences in their 3′ UTR that dictate their stability and translation through interaction with RNA-binding proteins, playing essential roles in many physiological and pathological processes[4][1][5][6][7]. It is not itself a canonical molecular target for drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on AU-rich element-containing messenger RNA.